Evidence map›Paper›PMID 33042826›Full record

ArticleFrontiers in oncology2020

Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in Madrid.

Antonio Calles, María Inmaculada Aparicio, Manuel Alva, Marianela Bringas, Natalia Gutierrez, Javier Soto, Marta Arregui, Victoria Clara Tirado, Enrique Luis Álvarez, María Del Monte-Millán and 4 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Observational
  13. Review
  14. Review
  15. New Normal for Lung Cancer Clinical Trials Under Coronavirus Disease 2019.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Antonio CallesMedical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
María Inmaculada AparicioMedical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Manuel AlvaMedical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Marianela BringasMedical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Natalia GutierrezMedical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Javier SotoMedical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Marta ArreguiMedical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Victoria Clara TiradoMedical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Enrique Luis ÁlvarezMedical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
María Del Monte-MillánMedical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Tatiana MassarrahMedical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Mar GaleraMedical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Rosa ÁlvarezMedical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Miguel MartínMedical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

coronavirusCOVID-19immunotherapylung cancermultivariateSARS-CoV-2targeted therapytocilizumab

Identifiers

PMID33042826
PMCPMC7525070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.